- Exchange: BSE India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Snapshot for Beryl Drugs Ltd (BRD)
| Open: | 26.35 | Day's Range: | 25.95 - 26.95 | Volume: | 63,902 |
|---|---|---|---|---|---|
| Previous Close: | 26.50 | 52wk Range: | 15.10 - 37.40 | 1-Yr Rtn: | +60.00% |
Key Statistics for BRD
| Current P/E Ratio (ttm) | 17.8667 |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SENSEX | 1.1058 |
| Earnings Per Share (ttm) | 1.5000 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M INR) | 137.51 |
| Shares Outstanding (M) | 5.13 |
| 30 Day Average Volume | 109,909 |
| Price/Book (mrq) | 2.4377 |
| Price/Sale (ttm) | 0.7935 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BRD
Company Profile & Key Executives for BRD
Beryl Drugs Ltd. manufactures generic drugs and intravenous fluids. The Company produces anti-bacterials, vitamins, analgesics, eye and ear drops, anti-inflammatories, anti-malarials, and anti-allergics. Beryl also manufactures veterinary medications and offers contract manufacturing services.
| Sanjay SethiChairman/Managing Director | Sudhir SethiExecutive Director |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BRD News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page